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The relation of smoking to the occurrence of the most com-
mon types of lung cancer has been examined and found
positive in epidemiological studies. Types that have been
causally ascribed to smoking in such studies have included
squamous cell, small and large cell, and adenocarcinomas
(US Dept of Health & Human Services, 1982; International
Agency for Research on Cancer, 1986). However, rarer types,
such as giant and alveolar cell carcinomas, have not been
subject to separate study, not only because of their rarity, but
because some pathologic classification systems for lung
cancer include these types with other histologies (Yesner &
Carter, 1982). While all histological types of lung cancer
studied thus far have been related to tobacco use and no type
has yet been found to be unrelated, there have been questions
raised about the relationship of smoking to these rarer types.
Giant cell carcinoma of the lung was first described by
Nash and Stout in 1958. Some investigators classify it as a
separate entity (Shin et al., 1986). On the other hand, some
have included it as a sub-type of adenocarcinoma of the lung,
while both the World Health Organization and the Armed
Forces Institute of Pathology include it with large cell
undifferentiated carcinoma (Razzuk el al., 1970). These
several schemes lead to non-uniform criteria in the literature
for diagnosis of pulmonary giant cell carcinoma. A survey
such as ours cannot resolve this difficulty and, therefore, we
must accept the cases reported as genuine for our purpose.
This survey is an attempt to provide some information
bearing on the aetiological relationship of giant cell car-
cinoma of the lung to smoking. We searched the literature, as
indexed by Medline through 1986, for case reports of pul-
monary giant cell carcinoma which included smoking his-
tories.
We found reports of 119 cases of pulmonary giant cell
carcinoma with smoking histories of the patients. Only eight
of these cases were female, five smokers and three non-
smokers, which are too few to analyse separately. Therefore,
we confined our analysis to males. The 111 male cases with
smoking data were found in 23 independent studies (Bendel
& Ishak, 1961; Broderick et al., 1975; Dailey & Marcuse,
1969; DeAngelis et al., 1961; Flanagan & Roeckel, 1964;
Friedberg, 1965; Gajaraj et al., 1971; Guillan & Zelman,
1966; Hathaway et al., 1969; Hellstrom & Fisher, 1963; Horie
& Ohta, 1981; Kallenberg & Jaque, 1979; Kennedy, 1969;
Lerner, 1967; Naib, 1961; Matsuo et al., 1986; Nash & Stout,
1958; Pfeffer & Stoven, 1978; Pfitzer & Knoblich, 1975; Shin
et al., 1986; Thomas, 1962; Wang et al., 1976). (Although not
reported as such in the publication, one woman in the study
of Shin et al. (1986) was a smoker, as were 8 of the 13 men;
Shin, personal communication.) We also found 99 other
cases, 81 male and 18 female, in other studies which did not
contain smoking information (12 references not cited).
Therefore, the male: female sex ratio for pulmonary giant cell
carcinoma is 7.4:1.
Of the 111 men with giant cell carcinoma of the lung, only
eight (7.2%) had been non-smokers. This 0.93 proportion of
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smokers among men with giant cell carcinoma of the lung
has a 95% confidence interval of 0.86-0.96 (Rothman &
Boice, 1979). This confidence interval does not come near to
overlapping any of the estimates of the prevalence of smok-
ing among US males and, therefore, is highly statistically
significant (Table I). Most reports did not include inform-
ation on the years or amount smoked, so we could not
examine the dose reponse.
Smoking prevalence data, based on a US national health
survey (US Dept of Health & Human Services, 1983), show
that 52%, 42% and 38% of all males were current smokers
in 1965, 1976 and 1980 respectively, while 20%, 30% and
31% were former smokers. Therefore, 72%, 72% and 69%
of US males had a positive smoking history in those years.
The prevalence of a history of smoking in males is then
about 71% over the period 1965-1980. Using that rate, one
can calculate a relative risk of 5.3 for pulmonary giant cell
carcinoma due to ever having smoked. Many of our 23 studies
did not distinguish between current and former smokers.
Therefore, the risk estimate of 5.3 is too low if the smoking
status in some of these studies included only current smokers.
To obtain an upper limit to this estimated risk, we can
compare our tabulation to the 44% mean prevalence of
current smoking in the US data from those three years. Such
calculation yields a risk ratio of 16. This range of risk
(5.3-16) is equal to or higher than the relative risks pub-
lished for other histological types of lung cancer (US Dept of
Health & Human Services, 1982; International Agency for
Research on Cancer, 1986). Our use of US smoking
prevalence for the years 1965-1980 as a population com-
parison is jsutified by the fact that the reports we used were
from 1958 to 1986, essentially the same period, and that 83%
of our reported cases were from the US.
There is a possibility that the authors of the case histories
may have mentioned a positive history of smoking more
readily than a negative one. This bias cannot be completely
excluded. However, in order to have the 95% confidence
limits (Rothman & Boice, 1979) of our observed proportion
overlap the expected 71% prevalence of a positive history of
smoking, at least 20 non-smokers must have been
unreported. This would mean that the non-smokers would
have to have been at least 70% under-reported for our result
to become non-significant, which is an unreasonably high
proportion.
In summary, we abstracted smoking data from 23 pub-
lished clinical reports of giant cell carcinoma of the lung in
111 men, of whom 93% were or had been smokers. This
proportion is significantly higher than the 71% prevelance of
a history of smoking among US men in the corresponding
Table I Prevalence of smokers among males
Smokers Odds ratio P value
Giant cell lung cancer cases 93% (98/111)
vs
US population 1965-80
Current smokers 44% 5.3 <0.001
Ever smokers 72% 16 <0.001
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years 1965-1980. Such an elevated proporiton of smokers
among these giant cell carcinoma cases is good evidence that
this form of lung cancer is causally related to smoking, as are
all other histological types that have been adequately studied
thus far (US Dept of Health & Human Services, 1982; Inter-
national Agency for Research on Cancer, 1986). Comparison
of this significantly higher proportion of smoking among
these cases also implies that the relative risk for giant cell
carcinoma of the lung is at least 5.3. This estimate is com-
parable to that for other histological types of lung cancer.
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